PT716602E - Efeito neuroprotector primario e secundario da flupirtina em doencas neurodegenerativas - Google Patents

Efeito neuroprotector primario e secundario da flupirtina em doencas neurodegenerativas

Info

Publication number
PT716602E
PT716602E PT94926828T PT94926828T PT716602E PT 716602 E PT716602 E PT 716602E PT 94926828 T PT94926828 T PT 94926828T PT 94926828 T PT94926828 T PT 94926828T PT 716602 E PT716602 E PT 716602E
Authority
PT
Portugal
Prior art keywords
pct
flupirtin
primary
neurodegenerative diseases
sec
Prior art date
Application number
PT94926828T
Other languages
English (en)
Inventor
Szelenyi Prof Stefan
Nickel Dr Bernd
Pergande Dr Gabriela
Jurgen Engel
Ulrich Dr Heinz
Michael Schwarz
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of PT716602E publication Critical patent/PT716602E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PT94926828T 1993-08-17 1994-08-10 Efeito neuroprotector primario e secundario da flupirtina em doencas neurodegenerativas PT716602E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4327516A DE4327516A1 (de) 1993-08-17 1993-08-17 Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin

Publications (1)

Publication Number Publication Date
PT716602E true PT716602E (pt) 2002-05-31

Family

ID=6495312

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94926828T PT716602E (pt) 1993-08-17 1994-08-10 Efeito neuroprotector primario e secundario da flupirtina em doencas neurodegenerativas

Country Status (27)

Country Link
US (1) US5721258A (pt)
EP (1) EP0716602B1 (pt)
JP (1) JPH09501664A (pt)
KR (1) KR100341952B1 (pt)
CN (1) CN1086291C (pt)
AT (1) ATE210442T1 (pt)
AU (1) AU694447B2 (pt)
BG (1) BG62430B1 (pt)
BR (1) BR9407293A (pt)
CA (1) CA2169718C (pt)
CZ (1) CZ289040B6 (pt)
DE (2) DE4327516A1 (pt)
DK (1) DK0716602T3 (pt)
EE (1) EE03204B1 (pt)
ES (1) ES2168309T3 (pt)
HR (1) HRP940464A2 (pt)
HU (1) HU227765B1 (pt)
IL (1) IL110681A (pt)
NO (1) NO309842B1 (pt)
NZ (1) NZ273292A (pt)
PT (1) PT716602E (pt)
RU (1) RU2166318C2 (pt)
SK (1) SK283330B6 (pt)
UA (1) UA43351C2 (pt)
WO (1) WO1995005175A1 (pt)
YU (1) YU49215B (pt)
ZA (1) ZA946176B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539861A1 (de) * 1995-10-26 1997-04-30 Asta Medica Ag Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
DE19541405A1 (de) * 1995-11-07 1997-05-15 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
ATE284684T1 (de) 1997-10-27 2005-01-15 Sumitomo Pharma Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
WO2001034172A2 (en) * 1999-11-05 2001-05-17 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome
WO2001039760A2 (en) * 1999-12-01 2001-06-07 Duke University Method of treating batten disease
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
CA2550023C (en) * 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
WO2006065204A1 (en) * 2004-12-14 2006-06-22 Astrazeneca Ab Substituted aminopyridines and uses thereof
EP1688141A1 (en) 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20060258708A1 (en) * 2005-05-16 2006-11-16 Andrulis Peter J Jr Method for treating Parkinson's disease and other neurological diseases
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102011006425A1 (de) 2010-03-31 2011-10-06 Awd.Pharma Gmbh & Co. Kg Pharmazeutische Zubereitung und deren Verwendung
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
MX2016001177A (es) * 2013-07-31 2016-04-29 Teva Pharma Tratamiento de esclerosis multiple con la combinacion de laquinimod y flupirtina.
WO2019014547A1 (en) * 2017-07-14 2019-01-17 Texas Tech University System FUNCTIONALIZED PYRIDINE CARBAMATES HAVING ENHANCED NEUROPROTECTOR ACTIVITY
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate
ATE25078T1 (de) * 1982-10-27 1987-02-15 Degussa 2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
DE3337593A1 (de) * 1982-10-27 1984-05-03 Degussa Ag, 6000 Frankfurt 2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
NO860825L (no) * 1985-03-23 1986-09-24 Degussa Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin.
IN172468B (pt) * 1990-07-14 1993-08-14 Asta Medica Ag

Also Published As

Publication number Publication date
ZA946176B (en) 1995-03-20
ATE210442T1 (de) 2001-12-15
CN1086291C (zh) 2002-06-19
NO309842B1 (no) 2001-04-09
EP0716602A1 (en) 1996-06-19
SK21496A3 (en) 1997-01-08
ES2168309T3 (es) 2002-06-16
CZ46596A3 (en) 1996-05-15
JPH09501664A (ja) 1997-02-18
NO960607L (no) 1996-02-15
HU9600355D0 (en) 1996-04-29
KR960703591A (ko) 1996-08-31
EP0716602B1 (en) 2001-12-12
DE69429435D1 (de) 2002-01-24
YU51294A (sh) 1998-05-15
HU227765B1 (en) 2012-02-28
DE4327516A1 (de) 1995-02-23
HUT75650A (en) 1997-05-28
NO960607D0 (no) 1996-02-15
BR9407293A (pt) 1996-10-01
CN1129399A (zh) 1996-08-21
US5721258A (en) 1998-02-24
YU49215B (sh) 2004-11-25
CZ289040B6 (cs) 2001-10-17
CA2169718C (en) 2002-11-12
IL110681A (en) 1999-08-17
BG100356A (bg) 1996-07-31
RU2166318C2 (ru) 2001-05-10
SK283330B6 (sk) 2003-06-03
IL110681A0 (en) 1994-11-11
HRP940464A2 (en) 1997-06-30
AU7652894A (en) 1995-03-14
AU694447B2 (en) 1998-07-23
BG62430B1 (bg) 1999-11-30
CA2169718A1 (en) 1995-02-23
EE03204B1 (et) 1999-08-16
KR100341952B1 (ko) 2003-04-11
DK0716602T3 (da) 2002-03-25
NZ273292A (en) 1999-09-29
UA43351C2 (uk) 2001-12-17
WO1995005175A1 (en) 1995-02-23
DE69429435T2 (de) 2002-06-13

Similar Documents

Publication Publication Date Title
PT716602E (pt) Efeito neuroprotector primario e secundario da flupirtina em doencas neurodegenerativas
PT703786E (pt) Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
AU678795B2 (en) Application of riluzole in the treatment of neurological lesions related to traumatic injuries
PT672041E (pt) Derivados da piridina farmacologicamente activos e processos para a sua preparacao
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
AU6357596A (en) Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
CZ176595A3 (en) The application of anticonvulsive agents for the preparation of medicaments intended for treating parkinson's disease and parkinson's syndromes
AU5225498A (en) Biaromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
HU9601684D0 (en) Deuterised active agents in transdermal application
MX9800049A (es) Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso.
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
BR9406865A (pt) Uso de um sal farmaceuticamente aceitável de ropivacaina na fabricaçao de um produto farmaceutico processo para o tratamento de uma pessoa necessitando de alivio da dor e preparaçao farmaceutica
AU4687501A (en) Medicine for treating traumatic brain injury and other neuronal disorders
NZ268914A (en) Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
HU9802142D0 (en) Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system